Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Uncover which credit card rewards program is best for your lifestyle. Compare various options to maximize your rewards potential.
23,688 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Meta is plowing ahead with AI investments. This article explains why the reason meta's spending spree could stay on t...
Tensions in the Persian Gulf surged after Bahrain said 41 people were detained in a crackdown tied to Iran’s Revoluti...
Nebius Group keeps powering higher as AI-driven data centers fuel growth. This article breaks down what’s behind the ...
Ondas stock moved sharply higher after a strong Q1 revenue beat and higher full-year guidance. This piece breaks down...
As AI expands, the biggest upside may come from the hyperscalers funding the cloud and data centers behind the scenes...
A potential energy shock could ripple through retail margins and consumer demand this summer. This guide explains wha...
In a volatile energy market, two durable picks stand out as no-brainer energy stocks right for many portfolios. Learn...
A high-profile SpaceX IPO could unleash a broad wave of capex across aerospace, semiconductors, and industrial suppli...
Toast is reshaping restaurant tech with a modular growth approach that blends software, payments, and services. This ...
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
California lawmakers return from summer break to push condo safety reforms, focusing on a true right-to-repair proces...